In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

David Auth: Riding Heart Technology's Roller Coaster

Executive Summary

Heart Technology is one of the great success stories in medical devices over the past 20 years. But you'd never have predicted that given the company's early experiences. In Vivo interviews the company's founder, David Auth.

You may also be interested in...



Pathway Medical: Pursuing the Hawk

Two years ago, Pathway Medical was nearly out of business. Now it's back, pursuing one of the hottest opportunities in cardiovascular medicine: atherectomy to treat peripheral artery disease.

FDA Publishes Raft Of Guidances To Promote Competition

The US FDA has published a raft of guidances on ANDA submissions and labeling updates as well as information requests and discipline review letters.

UK Government Narcotics Advisors Recommend 0.05mg THC Limit For CBD Products

An advisory body to the UK government recommends a single-dose limit of 50 micrograms tetrahydrocannabinol (THC) for cannabidiol food products sold in the country. An analysis by Canna Consultants suggests this might translate in practice to today's widely assumed, although technically false, 0.2mg per retail unit limit. 

Topics

Related Companies

Related Deals

UsernamePublicRestriction

Register

IV003164

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel